Yun Yen

Medicine & Life Sciences

1. Neoplasms 60%
2. ribonucleotide reductase M2 45%
3. Breast Neoplasms 35%
4. IT-101 28%
5. gemcitabine 27%
6. Hydroxyurea 22%
7. KB Cells 21%
8. Hepatocellular Carcinoma 20%
9. GTI2040 17%
10. Therapeutics 17%
11. DNA Damage 17%
12. Growth 16%
13. Biomarkers 16%
14. Cholangiocarcinoma 15%
15. Small Interfering RNA 15%
16. Colorectal Neoplasms 14%
17. Genes 14%
18. 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 14%
19. Camptothecin 14%
20. DNA Repair 14%
21. MPT0L145 13%
22. Cell Line 13%
23. Survival 13%
24. Drug Therapy 13%
25. Neoplasm Metastasis 13%
26. Receptor, Fibroblast Growth Factor, Type 3 12%
27. Pharmacokinetics 12%
28. Carcinogenesis 12%
29. In Vitro Techniques 11%
30. Cell Proliferation 11%
31. Liver Neoplasms 11%
32. Messenger RNA 11%
33. Clone Cells 11%
34. Proteins 10%
35. Heterografts 10%
36. MicroRNAs 10%
37. Bortezomib 10%
38. Nanoparticles 10%
39. Autophagy 10%
40. DNA 9%
41. Gene Expression 9%
42. Maximum Tolerated Dose 9%
43. Non-Small Cell Lung Carcinoma 9%
44. Arginine 9%
45. PHY 906 8%
46. cyclodextrin polymer 8%
47. Stem Cells 8%
48. Triple Negative Breast Neoplasms 8%
49. Apoptosis 8%